# ET Healthcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/et-healthcare

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.ethealthcare.com.cn
- Latest round: Series C (Sep 21, 2018)
- Investors on record: 5

## About

Established in 2012 and based in Shanghai, China, ET Healthcare, Inc., a subsidiary of Access Medical Systems, is a medical company that engages in the research and development of immunodiagnostic analysis equipment and reagents based on TOP (Test-On-A-Probe) biosensing technique. The company's founder and CEO, Hong Tan, received PhD and MSEE from Auburn University. He worked for several data storage companies, including Iomega, Seagate, and Maxtor.

The company's core product is fully automated immunoassay system, which uses a single-packed integrated reagent strip that can be directly tested with whole blood, and the results are reported within 20 minutes.

## Funding rounds

- Series C, Sep 21, 2018 — Maison Capital
- Series B, Nov 11, 2015 — Legend Capital, Qiming Venture Partners, Maison Capital, MPC, CEC Capital
- Series A, Mar 5, 2014 — Legend Capital, MPC

## Investors

- Legend Capital — Series A, Series B
- MPC — Series A, Series B
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Maison Capital (https://capitalatlas.ai/funds/maison-capital) — Series B, Series C
- CEC Capital (https://capitalatlas.ai/funds/cec-capital) — Series B